Integrative transcriptomic and network pharmacology analyses explore potential mechanisms underlying the protective effects of Mailuoning oral liquid after intracerebral hemorrhage in mice
Year: 2026
Type: article
Abstract: Background Secondary brain injury driven by neuroinflammation and blood–brain barrier (BBB) disruption contributes substantially to poor outcomes after intracerebral hemorrhage (ICH). Mailuoning oral liquid (MLN) has anti-inflammatory and vascular-protective activities; however, its protective effects and mechanisms in ICH remain unknown. Purpose To evaluate the protective effects of MLN after ICH and explore the potential underlying mechanisms. Methods A collagenase-induced ICH model was established in C57BL/6 J mice. Neurological deficits, brain injury, cerebral edema, BBB dysfunction, and BBB-related proteins were assessed. Transcriptomics and network pharmacology were integrated to identify candidate targets and pathways, followed by protein-level validation and phorbol 12-myristate 13-acetate (PMA) challenge. Results MLN improved neurological function, attenuated perihematomal injury and early hematoma burden, reduced cerebral edema and BBB leakage, increased claudin-5, occludin, and ZO-1, and decreased MMP-9. Transcriptomics identified 383 MLN-responsive genes enriched mainly in inflammatory and immune pathways, including NF-κB signaling. Network pharmacology independently identified 114 MLN–ICH targets and similarly highlighted inflammation-related pathways. Integrated analysis yielded 95 MLN-reversed ICH-responsive genes and three cross-supported candidates, F10, Ccl2, and Tnf. MLN reduced total NF-κB p65, TNF-α, IL-1β, and IL-6 protein expression, whereas PMA co-treatment partially attenuated MLN-associated improvements in neurological function and BBB-related protein expression. Conclusion MLN alleviates secondary brain injury and preserves BBB integrity after ICH. These protective effects may be associated with the modulation of NF-κB-related inflammatory responses and MMP-9-associated BBB alterations.
Source: Frontiers in Neurology
Institutions: Guizhou University, Guizhou Provincial People's Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226038853
